Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Prenetics Group ( (PRE) ) is now available.
On June 12, 2025, Prenetics Global Limited announced its unaudited financial results for the first quarter of 2025, revealing a significant revenue increase of 336.5% year-over-year to $14.4 million, excluding ACT Genomics. The company raised its full-year revenue outlook to $80-$100 million, reflecting strong business momentum. IM8, a subsidiary, showed remarkable growth with over 55,000 customers and 4.9 million servings delivered. Prenetics is also exploring strategic crypto initiatives to enhance its market positioning and drive long-term value creation.
The most recent analyst rating on (PRE) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Prenetics Group stock, see the PRE Stock Forecast page.
Spark’s Take on PRE Stock
According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.
Prenetics Group’s stock score is primarily impacted by its financial performance challenges, characterized by negative cash flow and profitability metrics. While technical analysis suggests some positive momentum, the negative valuation score due to profitability issues further weighs down the overall score.
To see Spark’s full report on PRE stock, click here.
More about Prenetics Group
Prenetics Global Limited is a leading health sciences company focused on advancing consumer and clinical health. The company operates through its consumer initiative, IM8, a health and wellness brand, and Europa, a major sports distribution company in the USA. Prenetics’ efforts are aimed at enhancing life through science, with a significant focus on global consumer healthcare markets.
Average Trading Volume: 22,102
Technical Sentiment Signal: Buy
Current Market Cap: $104.3M
For an in-depth examination of PRE stock, go to TipRanks’ Stock Analysis page.